MS Oncologie: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MS Oncologie
Largest movements
- Cash +€35,284
up €35,284 (+900,111%), from €4 to €35,288
mainly Net result for the year (+€28,752) and Tax, wage and social debts (+€16,427)
- Tangible fixed assets -€6,780
down €6,780 (-21.1%), from €32,075 to €25,296
- Deferred charges and accrued income +€5,565
up €5,565 (+54.7%), from €10,167 to €15,733
- Profit (loss) carried forward +€27,919
up €27,919 (+1,580%), from €1,767 to €29,686
- Tax, wage and social debts +€16,427
up €16,427 (+2,579%), from €637 to €17,064
- Debts after one year -€5,805
down €5,805 (-25.3%), from €22,944 to €17,139
- Other debts -€5,705
down €5,705 (-73.5%), from €7,766 to €2,062
- Gross operating margin +€41,119
up €41,119 (+824%), from €4,988 to €46,107
- Taxes +€8,440
up €8,440 (+1,325%), from €637 to €9,077
- Depreciation +€4,956
up €4,956 (+272%), from €1,824 to €6,780
- Financial charges +€676
up €676 (+144%), from €469 to €1,145
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €42,247 | €76,316 | +€34,070 | +80.6% |
| Fixed assets | 21/28 | €32,075 | €25,296 | -€6,780 | -21.1% |
| Tangible fixed assets | 22/27 | €32,075 | €25,296 | -€6,780 | -21.1% |
| Furniture and vehicles | 24 | €32,075 | €25,296 | -€6,780 | -21.1% |
| Current assets | 29/58 | €10,171 | €51,021 | +€40,850 | +402% |
| Cash at bank and in hand | 54/58 | €4 | €35,288 | +€35,284 | +900,111% |
| Deferred charges and accrued income | 490/1 | €10,167 | €15,733 | +€5,565 | +54.7% |
| Total equity and liabilities | 10/49 | €42,247 | €76,316 | +€34,070 | +80.6% |
| Equity | 10/15 | €4,767 | €32,686 | +€27,919 | +586% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,767 | €29,686 | +€27,919 | +1,580% |
| Amounts payable | 17/49 | €37,479 | €43,630 | +€6,151 | +16.4% |
| Amounts payable after more than one year | 17 | €22,944 | €17,139 | -€5,805 | -25.3% |
| Financial debts | 170/4 | €22,944 | €17,139 | -€5,805 | -25.3% |
| Amounts payable within one year | 42/48 | €14,535 | €26,051 | +€11,516 | +79.2% |
| Current portion of amounts payable after more than one year | 42 | €5,591 | €5,805 | +€215 | +3.8% |
| Trade debts | 44 | €541 | €1,120 | +€580 | +107% |
| Suppliers | 440/4 | €541 | €1,120 | +€580 | +107% |
| Taxes, remuneration and social security | 45 | €637 | €17,064 | +€16,427 | +2,579% |
| Taxes | 450/3 | €637 | €17,064 | +€16,427 | +2,579% |
| Other amounts payable | 47/48 | €7,766 | €2,062 | -€5,705 | -73.5% |
| Accrued charges and deferred income | 492/3 | - | €440 | +€440 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,824 | €6,780 | +€4,956 | +272% |
| Other operating charges | 640/8 | €290 | €354 | +€63 | +21.8% |
| Gross operating margin | 9900 | €4,988 | €46,107 | +€41,119 | +824% |
| Operating profit (loss) | 9901 | €2,873 | €38,973 | +€36,100 | +1,256% |
| Financial charges | 65/66B | €469 | €1,145 | +€676 | +144% |
| Recurring financial charges | 65 | €469 | €1,145 | +€676 | +144% |
| Profit (loss) for the period before taxes | 9903 | €2,404 | €37,829 | +€35,424 | +1,473% |
| Income taxes | 67/77 | €637 | €9,077 | +€8,440 | +1,325% |
| Profit (loss) for the period | 9904 | €1,767 | €28,752 | +€26,984 | +1,527% |
| Profit (loss) for the period to be appropriated | 9905 | €1,767 | €28,752 | +€26,984 | +1,527% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.